Strides Pharma Science Limited has informed the Exchange about Intimation pursuant to Regulation 31A of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations )
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Both BSE and NSE have approved Strides Pharma Science's application to reclassify Shasun Leasing and Finance Private Limited from the 'Promoter Group' to the 'Public' category under SEBI Regulation 31A. The original application was filed on August 22, 2024, and the approval was granted on June 27, 2025. Notably, Shasun Leasing and Finance holds 0 shares in the company, so the reclassification is purely a formal/technical categorization change. Promoter holding remains at 2,60,77,845 shares (28.30%) and public holding at 6,60,84,869 shares (71.70%), with no change before and after the reclassification.
This is a procedural housekeeping announcement with no material impact on shareholding or stock price. The entity being reclassified holds zero shares, so there is no change in promoter or public shareholding percentages. Existing investors should not expect any change in ownership structure or trading dynamics.